These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9026270)

  • 1. Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus.
    Tojo C; Takao T; Nishioka T; Numata Y; Suemaru S; Hashimoto K
    Endocr J; 1996 Apr; 43(2):233-9. PubMed ID: 9026270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L; Priou A; Oliver C; Grino M
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint.
    Zelena D; Mergl Z; Foldes A; Kovács KJ; Tóth Z; Makara GB
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1110-7. PubMed ID: 14534078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
    Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses.
    Chan O; Chan S; Inouye K; Shum K; Matthews SG; Vranic M
    Diabetes; 2002 Jun; 51(6):1681-9. PubMed ID: 12031953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased adrenocorticotropin responses to acute stress in Otsuka Long-Evans Tokushima Fatty (type 2 diabetic) rats.
    Takao T; Tojo C; Nishioka T; Hashimoto K
    Brain Res; 2000 Jan; 852(1):110-5. PubMed ID: 10661502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
    Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2001 Jun; 13(6):561-6. PubMed ID: 11412343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status.
    De Goeij DC; Dijkstra H; Tilders FJ
    Endocrinology; 1992 Aug; 131(2):847-53. PubMed ID: 1322285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
    J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of sex and gonadectomy on the hypothalamo-pituitary-adrenal axis of the sheep.
    Canny BJ; O'Farrell KA; Clarke IJ; Tilbrook AJ
    J Endocrinol; 1999 Aug; 162(2):215-25. PubMed ID: 10425459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis up-regulation in rats submitted to pituitary stalk compression.
    Elias PC; Elias LL; Castro M; Antunes-Rodrigues J; Moreira AC
    J Endocrinol; 2004 Feb; 180(2):297-302. PubMed ID: 14765982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.